P3 Health Partners PE Ratio 2020-2026 | PIII
Current and historical p/e ratio for P3 Health Partners (PIII) from 2020 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. P3 Health Partners PE ratio as of September 18, 2026 is 0.00.
| P3 Health Partners PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-09-18 | 7.67 | 0.00 | |
| 2026-06-30 | 10.80 | $-33.06 | 0.00 |
| 2026-03-31 | 3.08 | $-38.66 | 0.00 |
| 2025-12-31 | 3.49 | $-45.26 | 0.00 |
| 2025-09-30 | 8.95 | $-45.31 | 0.00 |
| 2025-06-30 | 6.30 | $-51.34 | 0.00 |
| 2025-03-31 | 8.21 | $-52.48 | 0.00 |
| 2024-12-31 | 11.25 | $-54.06 | 0.00 |
| 2024-09-30 | 19.32 | $-40.93 | 0.00 |
| 2024-06-30 | 22.52 | $-31.23 | 0.00 |
| 2024-03-31 | 51.50 | $-28.36 | 0.00 |
| 2023-12-31 | 70.50 | $-31.50 | 0.00 |
| 2023-09-30 | 73.50 | $-134.00 | 0.00 |
| 2023-06-30 | 149.50 | $-141.50 | 0.00 |
| 2023-03-31 | 53.00 | $-323.50 | 0.00 |
| 2022-12-31 | 92.00 | $-325.00 | 0.00 |
| 2022-09-30 | 231.00 | $-212.50 | 0.00 |
| 2022-06-30 | 186.00 | $-199.00 | 0.00 |
| 2022-03-31 | 391.00 | $-12.50 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.057B | $1.459B |
| P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $42.703B | 42.61 |
| Tempus AI (TEM) | United States | $14.500B | 0.00 |
| 10x Genomics (TXG) | United States | $10.029B | 0.00 |
| Hinge Health (HNGE) | United States | $7.643B | 73.43 |
| Hims & Hers Health (HIMS) | United States | $6.507B | 0.00 |
| Doximity (DOCS) | United States | $4.736B | 29.20 |
| Heartflow (HTFL) | United States | $4.310B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.684B | 242.93 |
| Privia Health (PRVA) | United States | $2.566B | 95.67 |
| Clover Health Investments (CLOV) | United States | $2.411B | 0.00 |
| Schrodinger (SDGR) | United States | $2.232B | 0.00 |
| Butterfly Network (BFLY) | United States | $2.120B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.103B | 32.04 |
| Omnicell (OMCL) | United States | $1.484B | 21.18 |
| Azenta (AZTA) | United States | $1.473B | 80.07 |
| Enovis (ENOV) | United States | $1.027B | 5.31 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.716B | 0.00 |
| Phreesia (PHR) | United States | $0.638B | 34.27 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Veradigm (MDRX) | United States | $0.587B | 0.00 |
| Claritev (CTEV) | United States | $0.538B | 0.00 |
| Carlsmed (CARL) | United States | $0.420B | 0.00 |
| Evolent Health (EVH) | United States | $0.415B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.394B | 0.00 |
| CapsoVision (CV) | United States | $0.317B | 0.00 |
| Standard BioTools (LAB) | United States | $0.287B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.135B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.094B | 6.94 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Outset Medical (OM) | United States | $0.058B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.058B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.047B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.027B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| HeartSciences (HSCS) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |